Key Takeaways for UiPath Stock as of September 2026
- Guidance Whiplash: UiPath stock sank 17% on Friday, September 4 after fiscal Q2 revenue of $410.3M beat estimates, but Q3 guidance of $440M to $445M implies growth slowing to 8% YoY from Q2’s 13%.
- Street Lag: UiPath stock’s $16 mean target sits just 8% above Friday’s $15 close, the thinnest cushion since spring, and only 1 of 20 covering analysts rates it a buy.
- Model Gap: TIKR’s mid-case model still values UiPath stock at $21, a 36% total return.
- Rally Unwind: Heading into the print, UiPath stock had already climbed 30% over the trailing three months, stretching its forward P/E from 15x to 21x.
A raised full-year outlook didn’t stop UiPath stock from dropping 17% in a day. See what TIKR’s valuation model makes of that gap. Explore UiPath stock on TIKR for free →
Why UiPath Stock Sank 17% on a Beat-and-Raise Quarter
UiPath (PATH) stock sank 17% on Friday, September 4, after a fiscal second-quarter beat on revenue and operating income came wrapped in a Q3 revenue outlook that points to growth of just 8%, half of Q2’s 13% pace.
The fiscal second quarter itself was clean by nearly every measure. Revenue rose 13% year over year to $410.3 million, beating the $397.9 million analysts expected. Non-GAAP operating income hit $89 million, a 22% margin and more than 400 basis points above the year-ago quarter, and adjusted earnings of $0.15 per share matched estimates. Annualized recurring revenue, the subscription base UiPath draws its long-term value from, climbed 12% to $1.94 billion, and dollar-based net retention held at 109%.
Then came the guide. UiPath pointed third-quarter revenue toward $440 million to $445 million and lifted full-year revenue guidance only modestly, to $1.789 billion and $1.794 billion from a prior range near $1.776 billion and $1.781 billion. A raise is still a raise. But next to Q2’s 13% growth, a Q3 range implying 8% reads like deceleration dressed up as good news.
Billings, the cash UiPath actually invoiced during the quarter, grew 24.8% year over year to $375.5 million but landed just short of what the Street modeled. That shortfall matters more than its size suggests. Billings are a leading indicator of pipeline converting into contract, and a miss there, even a slim one, is the kind of detail that turns a beat-and-raise print into a growth-scare selloff.
Hitesh Ramani, promoted this same quarter from deputy CFO to the top finance seat, framed the caution as discipline rather than weakness. “Our philosophy here is unchanged. We guide to what we see in front of us, and we maintain a prudent outlook,” he told analysts on the call. Investors heard something less reassuring: a newly installed CFO leaning on conservatism just as growth was already cooling.
Context made the guide land harder. Heading into the print, UiPath stock had already climbed 30% over the trailing three months, and its forward price-to-earnings multiple had stretched from 15 times estimated earnings to 21 times. A market paying up for reacceleration got a deceleration signal instead, and the reset was swift.
UiPath stock did not fall because the business missed. It fell because the pace of expansion that justified its valuation is slowing exactly as the stock finished a run that had already priced in the opposite.
UiPath just guided Q3 growth to 8%, half its current pace. Pull the full ARR and billings trend for yourself. Track UiPath stock on TIKR for free →
UiPath Stock’s Mean Target Barely Clears the New Price
Street targets put UiPath stock’s current ratings at 1 buy, 1 outperform, 17 holds and 1 underperform among the 20 analysts it tracks, a lineup tilted almost entirely toward hold. The mean target sits at $16, just 8% above Friday’s $15 close, the thinnest premium the stock has carried over its price in over a year.
That cushion has been shrinking for months, not widening. Back in April 2026, with the stock trading near $10, the mean target of $14 sat 34% above the price. By July, after most of the rally had already happened, the gap had narrowed to just 4% over a $13 close, even as coverage held steady at 16 analysts publishing price targets.
Analysts have since lifted the mean target 24% to the current $16, catching up to the stock’s run rather than getting ahead of it, and the number of buy-rated analysts fell from 2 to just 1 over that same stretch, a Street that raised its number but not its conviction.
TIKR Values UiPath Stock at $21, Pricing In a Reacceleration
TIKR’s mid-case model values UiPath stock at $21 by January 2031, implying 36% total return from the current price of $15, or 7% annualized over the next 4.4 years.
A 7% annualized return is a mature-software pace, not a hypergrowth one, and it puts UiPath stock’s re-rating case on execution rather than a return to 13%-plus growth.
That is a lower bar than Friday’s selloff implies. UiPath stock still carries $1.4 billion in cash and no debt, ARR growing in the low teens, and a Street mean target of $16 that, even after the drop, sits above the current price, all of which give the model’s $21 case room to work without needing Q3’s 8% guide to reaccelerate.
TIKR’s model puts UiPath stock at $21, a 36% return by 2031. Check the assumptions behind that call. Model UiPath stock on TIKR for free →
Should You Invest in UiPath, Inc.?
The only way to really know is to look at the numbers yourself. TIKR gives you free access to the same institutional-quality financial data that professional analysts use to answer exactly that question.
Pull up UiPath, Inc. stock and you’ll see years of historical financials, what Wall Street analysts expect for revenue and earnings in the quarters ahead, how valuation multiples have moved over time, and whether price targets are trending up or down.
You can build a free watchlist to track UiPath, Inc. alongside every other stock on your radar. No credit card required. Just the data you need to decide for yourself.
Access Professional Tools to Analyze PATH stock on TIKR for Free →
Looking for New Opportunities?
- See what stocks billionaire investors are buying so you can follow the smart money.
- Analyze stocks in as little as 5 minutes with TIKR’s all-in-one, easy-to-use platform.
- The more rocks you overturn… the more opportunities you’ll uncover. Search 100K+ global stocks, global top investor holdings, and more with TIKR.
Disclaimer:
Please note that the articles on TIKR are not intended to serve as investment or financial advice from TIKR or our content team, nor are they recommendations to buy or sell any stocks. We create our content based on TIKR Terminal’s investment data and analysts’ estimates. Our analysis might not include recent company news or important updates. TIKR has no position in any stocks mentioned. Thank you for reading, and happy investing!
